GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 3651 - 3700 of 39437 in total
PDB ID UniProt ID ▲ Title Descriptor
7FBJ 7FBJ Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6
7FBK 7FBK Crystal structure of SARS-CoV-2 receptor binding domain N501Y mutant in complex with neutralizing nanobody 20G6
7FBL 7FBL Thrombocorticin in complex with Ca2+ and mannose
7FBP 7FBP FXIIa-cMCoFx1 complex
7FCP 7FCP Crystallographic structure of two neutralizing antibodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
7FCQ 7FCQ Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
7FGB 7FGB A naturally-occurring neuraminidase-inhibitors-resistant NA from asiatic toad influenza B-like virus
7FGC 7FGC A naturally-occurring neuraminidase-inhibitors-resistant NA from asiatic toad influenza B-like virus
7FH0 7FH0 Crystallographic structure of two neutralizing nanobodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
7FIG 7FIG luteinizing hormone/choriogonadotropin receptor(S277I)-chorionic gonadotropin-Gs complex
7FJC 7FJC Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab
7FJN 7FJN Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
7FJO 7FJO Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab
7FJS 7FJS Crystal structure of T6 Fab bound to theSARS-CoV-2 RBD of B.1.351
7JHG 7JHG Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody
7JHH 7JHH Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody
7JIX 7JIX Murine antibody that engages the influenza hemagglutinin receptor binding site
7JKS 7JKS Crystal structure of vaccine-elicited broadly neutralizing VRC01-class antibody 2411a in complex with HIV-1 gp120 core
7JKT 7JKT Crystal structure of vaccine-elicited broadly neutralizing VRC01-class antibody 2413a in complex with HIV-1 gp120 core
7JMO 7JMO Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04
7JMP 7JMP Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39
7JMW 7JMW Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab
7JN5 7JN5 Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022
7JOO 7JOO Crystal structure of ICOS in complex with antibody STIM003 and anti-kappa VHH domain
7JPH 7JPH Crystal structure of EBOV glycoprotein with modified HR1c and HR2 stalk at 3.2 A resolution
7JPI 7JPI Crystal structure of EBOV glycoprotein with modified HR2 stalk at 2.3A resolution
7JTG 7JTG Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody RM11-43
7JTR 7JTR Complex of maltose-binding protein (MBP) with single-chain Fv (scFv)
7JTV 7JTV Structure of IMPa from Pseudomonas aeruginosa in complex with an O-glycopeptide
7JV4 7JV4 SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
7JV6 7JV6 SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) SARS-CoV-2 spike glycoprotein, S2H13 Fab heavy chain, S2H13 Fab light chain
7JVA 7JVA SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) S2A4 Fab heavy chain, S2A4 Fab light chain, SARS-CoV-2 spike glycoprotein
7JVC 7JVC SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment SARS-CoV-2 spike glycoprotein, S2A4 Fab heavy chain, S2A4 Fab light chain
7JVD 7JVD Fab of 5.6 monoclonal mouse IgG1 co-crystallized with the trisaccharide form of serotype 3 pneumococcal capsular polysaccharide
7JW0 7JW0 SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment SARS-CoV-2 spike glycoprotein, S304 Fab light chain, S304 Fab heavy chain
7JW4 7JW4 Crystal structure of PdGH110B in complex with D-galactose
7JWF 7JWF Crystal structure of PdGH110B D344N in complex with alpha-(1,3)-galactobiose
7JX3 7JX3 Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology
7JZ4 7JZ4 Crystal structure of broadly Plasmodium RIFIN reactive LAIR1-inserted antibody MGD21
7JZK 7JZK Crystal structure of LAIR1 ectodomain (from MGD21) in complex with Plasmodium RIFIN (PF3D7_0401300) V2 domain
7JZL 7JZL SARS-CoV-2 spike in complex with LCB1 (2RBDs open) Spike glycoprotein,LCB1
7JZM 7JZM SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3) LCB3,spike glycoprotein
7JZN 7JZN SARS-CoV-2 spike in complex with LCB3 (2RBDs open) Spike glycoprotein,LCB3
7JZU 7JZU SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1) LCB1,Spike glycoprotein
7K0X 7K0X Marsupial T cell receptor Spl_145
7K0Z 7K0Z Marsupial T cell receptor Spl_157
7K37 7K37 Structure of full-length influenza HA with a head-binding antibody at pH 7.8 Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain
7K39 7K39 Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation A, neutral pH-like Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain
7K3A 7K3A Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation B, fusion peptide release Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain
7K3B 7K3B Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation C, central helices splay Hemagglutinin, antibody Fab light chain, antibody Fab heavy chain

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024